Supplemental Cash Flow Information

12 Months Ended

Dec. 31, 2022

Supplemental Cash Flow Elements [Abstract]

Supplemental Cash Flow Information

NOTE 17. Supplemental Cash Flow Information

The following table provides supplemental cash flow information (in thousands):

	Year Ended December 31,
	2022		2021		2020
Supplemental cash flow information:
Interest paid	$	3,672	$	4,824	$	7,086
Income taxes paid (refunded), net		5,313		1,819		2
Supplemental disclosure of non-cash financing activities:
Reclassification of contingently redeemable common stock    in connection with IPO		—		309,500		—
Issuance of common stock under partner physician group    equity agreements upon IPO		—		268,467		—
Offering costs accrued at end of period		—		295		—
Non-cash investment in unconsolidated subsidiaries		190		763		—
Settlement of stock-based liabilities		—		—		1,500
Settlement of loans receivable with services provided		—		—		2,047

The following table summarizes cash, cash equivalents and restricted cash equivalents from continuing operations (in thousands):

	December 31,
	2022		2021
Cash and cash equivalents	$	497,070	$	1,040,039
Restricted cash and equivalents		10,610		14,781
Cash, cash equivalents and restricted cash equivalents	$	507,680	$	1,054,820